Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy

Luisa Calvanese1, Annalia Focà2, Annamaria Sandomenico3

  • 1CIRPeB, University of Naples Federico II, via Mezzocannone, 16, 80134 Napoli, Italy.

Insights

Researchers mapped the atomic-level interactions between the Nodal growth factor and a high-affinity antibody (3D1). This study elucidates critical binding sites, aiding in the development of targeted cancer therapies by inhibiting Nodal signaling.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Oncology

Background:

  • Nodal is a growth factor crucial in embryonic development, often reactivated in advanced cancers.
  • Nodal signaling, mediated by the Cripto-1 co-receptor, promotes cancer cell aggressiveness and tumor growth.
  • Targeting Nodal signaling offers a therapeutic strategy to inhibit cancer progression.

Purpose of the Study:

  • To identify and characterize the atomic-level interaction surface between Nodal and its co-receptor binding region.
  • To investigate the binding interface of Nodal with the high-affinity monoclonal antibody (3D1) using biophysical techniques.
  • To confirm and refine previous findings on Nodal-Cripto-1 interactions at the molecular level.

Main Methods:

  • Saturation Transfer Difference Nuclear Magnetic Resonance (STD-NMR) spectroscopy was employed to study molecular interactions.
  • Analysis of Nodal fragments interacting with the 3D1 antibody.
  • Comparison of NMR data with previous immune-enzymatic assay results.

Main Results:

  • The study precisely mapped the antibody-antigen contact points at an atomic level.
  • Key residues P46, V47, E49, and E50 on Nodal were identified as primary contact sites for the 3D1 antibody.
  • These residues are located within the Nodal loop critical for Cripto-1 co-receptor binding.

Conclusions:

  • The 3D1 antibody binds to a specific Nodal surface involved in co-receptor interaction.
  • Structural insights at the atomic level validate the antibody's binding epitope.
  • This detailed understanding facilitates the rational design of Nodal-targeting therapeutics for cancer treatment.

Related Concept Videos

¹H NMR: Complex Splitting01:13

¹H NMR: Complex Splitting

A proton M that is coupled to a proton X results in doublet signals for M. However, NMR-active nuclei can be simultaneously coupled to more than one nonequivalent nucleus. When M is coupled to a second proton A, such as in styrene oxide, each peak in the doublet is split into another doublet.
Splitting diagrams or splitting tree diagrams are routinely used to depict such complex couplings. While drawing splitting diagrams, the splitting with the larger coupling constant is usually applied...
1.9K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.9K
Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule01:10

Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule

In the AX proton spin system, proton A can sense the two spin states of a coupled proton X, resulting in a doublet NMR signal with two peaks of equal (1:1) intensity. When proton A is coupled to two equivalent protons (AX2 spin system), the spin states of each X can be aligned with or against the external field, creating three possible scenarios. This results in a 1:2:1  triplet signal, where the central peak corresponds to the chemical shift of A and is twice as large or intense as the...
2.7K